Financials • Life Insurance
$35.29 ▼ -0.03
(-0.08%)
MKT CAP: $15.73B • VOL: 4.95M
52W L $22 52W H $36
CRBG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $18.48B | $18.71B | $18.80B |
| YoY Revenue Growth % | -1.2% | -0.5% | — |
| Gross Profit | $8.13B | $8.23B | $8.27B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$431.9M | $2.63B | $1.30B |
| Operating Margin % | -2.3% | 14.1% | 6.9% |
| Net Income (GAAP) | -$366.0M | $2.23B | $1.10B |
| EBITDA (Normalized) | $233.4M | $3.30B | $1.98B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.02B | $2.15B | $3.36B |
| Capital Expenditures (CapEx) | $831.6M | $841.8M | $846.0M |
| Free Cash Flow (FCF) | $1.19B | $1.31B | $2.51B |
| FCF Margin % | 6.4% | 7.0% | 13.4% |
| Return on Invested Capital (ROIC %) | -0.2% | 1.5% | 7.6% |
| Cash & Short-Term Equivalents | $45.49B | $42.83B | $2.48B |
| Total Debt (Short + Long Term) | $179.81B | $169.68B | $5.28B |
| Total Stockholders' Equity | $13.20B | $11.46B | $10.83B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CRBG.